NCI-H23 In Vitro Agarose Gel Electrophoresis-based DNA Fragmentation Assay (Apoptosis )
CAT#: ITS-0123-YF1510
Target Cell Organism: Human
Target Cell Alternative Name: H23
Target Cell Name: NCI-H23
Assay Type: Detection of Apoptosis Assays
Assay Overview
This assay is to provide NCI-H23-based In Vitro Agarose Gel Electrophoresis-based DNA Fragmentation Assay (Apoptosis ) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H23
Target Cell Organism
Human
Target Cell Background
NCI-H23 [H23] is an epithelial-like cell that was isolated from the lung of a Black, 51-year-old, male patient with adenocarcinoma. This cell line was deposited by AF Gazdar and JD Minna and can be used in toxicology and cancer research.
Target Cell Alternative Name
H23
Related Diseases
Non Small Cell Lung Cancer
Research Area
Oncology
Assay Name
In Vitro Agarose Gel Electrophoresis-based DNA Fragmentation Assay (Apoptosis )
Assay Description
Laddering of fragmented DNA (oligo-nucleosomal fragments) is detected by agarose gel electrophoresis after staining with DNA intercalating dyes such as ethidium bromide, PI or SYBR green.
Assay Type
Detection of Apoptosis Assays
Assay Type Details
Apoptosis (programmed cell death) plays a vital role in embryonic development, homeostasis, functioning of immune system and wound repair. The ability to evade induction of apoptosis has been used by cancer cells to survive against host defense mechanisms. The molecular mechanisms involved in cancer cell apoptosis have been well documented and it involves certain biochemical events such as DNA fragmentation, chromatin condensation, cell organelle degradation and protein cleavage, etc. The extrinsic and intrinsic (mitochondrial) pathways are the two major pathways involved in apoptosis. With the available techniques and assays, a number of apoptosis inducing agents (natural compounds, synthetic compounds, nano-formulations, peptides and enzymes) in many cancer cells have been identified. Selection of an assay for apoptosis detection is based on factors such as apoptotic pathway, nature of drug, cell type being used and the method of analysis.